Clinical trials in Kyustendil – page 2

Innovative research focusing on respiratory syncytial virus (RSV) and human metapneumovirus infections, with trials evaluating novel vaccine technologies and therapeutic interventions for adults and at-risk populations.

• RSV Prevention and Treatment
• Viral Lower Respiratory Tract Disease
• Vaccine Development

Studies include assessment of advanced therapeutics like EDP-938 for acute infections.

Groundbreaking studies examining atherosclerotic cardiovascular disease prevention and treatment, with particular focus on innovative therapies to reduce major adverse cardiovascular events.

• Primary and Secondary Prevention
• Lipid Management
• Cardiovascular Risk Reduction

Clinical trials evaluating inclisiran's effectiveness in preventing heart attacks and strokes.

Comprehensive research into thalassemia and related blood disorders, investigating new treatments for both transfusion-dependent and non-transfusion-dependent patients.

• Thalassemia Management
• Anemia Treatment
• Polycythemia Vera Studies

Trials include evaluation of mitapivat and novel therapeutic approaches for blood disorders.

Advanced research targeting hypertriglyceridemia, including severe forms, with trials evaluating innovative treatments for lipid management.

• Triglyceride Level Management
• Metabolic Disease Treatment
• Long-term Safety Studies

Multiple studies examining plozasiran's effectiveness in treating various forms of hypertriglyceridemia.

Important research in childhood immunization, focusing on the development and safety assessment of vaccines for common childhood diseases.

• Varicella Prevention
• Vaccine Safety Studies
• Pediatric Immunology

Studies include evaluation of chickenpox vaccine safety in young children.